#46
|
||||
|
||||
Âñå èññëåäîâàíèÿ ïðîâåäåíû è äàâíî óæå âñå äîêàçàíî, ñ 2000 ãîäà ïðîâîäÿòñÿ èññëåäîâàíèÿ ñ ïîëîæèòåëüíûìè ðåçóëüòàòàìè êàê íà ñâèíûõ ìîäåëÿõ òàê è ñ ëþäüìè ñ ðàçðåøåíèÿ ýòè÷åñêîãî êîìèòåòà, áåç ïðîöåäóðíûõ îñëîæíåíèé èëè îòðèöàòåëüíûõ âîçäåéñòâèé, åñòü ìàññà íàó÷íî äîêàçàòåëüíîé ëèòåðàòóðû… Ê ñîæàëåíèþ íàâåðíÿêà âû åå íå ÷èòàëè…
Çà÷åì äîêàçûâàòü òî ÷òî óæå äàâíî äîêàçàíî??? |
#47
|
||||
|
||||
Óâàæàåìûé Âàäèì Âàëåðüåâè÷ äåíåã ìû ñî ñâîèõ ïàöèåíòîâ íå áåðåì…
Äàæå â Åâðîïå ïðèìåíåíèå óäàðíî-âîëíîâîé òåðàïèè ÿâëÿåòñÿ ïëàòíûì ëå÷åíèåì ïîñêîëüêó íå îïëà÷èâàåòñÿ ñòðàõîâêîé – ñòîèò ýòî 1.000 åâðî… Ó íàñ åäèíñòâåííûé ãîðîä â Ðîññèè ãäå âñÿ ìåäèöèíà áåñïëàòíà, âêëþ÷àÿ ñàìûå ïîñëåäíèå ïåðåäîâûå òåõíîëîãèè! |
#48
|
||||
|
||||
Óâàæàåìûé Ñåðãåé, îáüÿñíèòå ìíå êàê êàðäèîëîã ãåìàòîëîãó, çà÷åì ïîíàäîáèëîñü ÿïîíñêèì êàðäèîëîãàì, êîòîðûå ñòîÿëè ó èñòîêîâ èçîáðåòåíèÿ ïðèáîðà è åäèíñòâåííûå, êòî îïóáëèêîâàë ðåçóëüòàò ýêñïåð. ðàáîòû íà ëþäÿõ (9 ÷åëîâåê â 2006 - ìàêñèìàëüíîå ÷èñëî ïàöèåíòîâ, èáî îñòàëüíûå íîðìàëüíûå ïóáëèêàöèè ñ 2003-2009 ãã îïèñûâàþò åäèí. êëèíè÷åñêèå íàáëþäåíèÿ) ïèñàòü î íà÷àëå êëèíè÷åñêîãî ïëàöåáî-òðàéëà â 2009 ãîäó, êîãäà ïî Âàøèì äàííûì óæå âñå èçâåñòíî ñ 2000-ãî ãîäà?
Ïî àíàëîãèè - åñëè îïóáëèêîâàíî 6-10 åäèíè÷íûõ êåéñ-ðåïîðòîâ è 2-3 ñòàòüè ëè÷íîãî îïûòà äîêòîðîâ íà 10-15 ïàöèåíòàõ îá óñïåøíîñòè Àðèêñòðû ïðè ãåïàðèí-èíäóöèð. òðîìáîöèòîïåíèè (ÃÈÒ), ìîæíî ëè óòâåðæäàòü, ÷òî Àðèêñòðà áåçîïàñíà ó âñåõ ïàöèåíòîâ ñ ÃÈÒ è íå ìåíåå ýôôåêòèâíà, ÷åì àãàòðîáàí?
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#49
|
||||
|
||||
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#50
|
||||
|
||||
Åùå îäíà ñâåæàÿ ïóáëèêàöèÿ ïî òåìå, äîñòóïíàÿ ñâîáîäíî:
Case Report Med. 2009;2009:639594. Extracorporeal cardiac shock wave therapy ameliorates clinical symptoms and improves regional myocardial blood flow in a patient with severe coronary artery disease and refractory angina. Prinz C, Lindner O, Bitter T, Hering D, Burchert W, Horstkotte D, Faber L. Êëþ÷åâûå ñëîâà îòòóäà (âûäåëåíî ìíîé): a 51-year-old female with CAD and refractory angina pectoris despite maximally tolerated medical therapy and after both percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). The patient received cardiac shock wave therapy (CSWT) over a period of 6 month. Our case report suggests that ultrasound-guided CSWT is able to improve symptoms and perfusion in ischemic myocardium which is beyond mechanical revascularization. However, a controlled trial is needed to define the role of CSWT in the armamentarium for these challenging patients.
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#51
|
||||
|
||||
ß íå çíàþ îò êóäà ó âàñ ýòè äàííûå è çà÷åì âàì ñòîëü ÿðîñòíûé èíòåðåñ ê ÓÂÒ êàê ãåìàòîëîãó??? Åñëè äåéñòâèòåëüíî âû çàèíòåðåñîâàíû äàííîé òåìîé ÿ ìîãó âàñ âûñëàòü âñþ «êèïó» èìåþùåéñÿ ó ìåíÿ ëèòåðàòóðû è ýëåêòðîííûå àäðåñà ßïîíñêèõ è Øâåéöàðñêèõ ïðîôåññîðîâ çàíèìàþùèõñÿ äàííîé òåìîé…
Èç ëè÷íîãî îïûòà – àðèêñòðà çàìå÷àòåëüíûé ïðåïàðàò, íå êàêèå ïàòîëîãè÷åñêèå âîçäåéñòâèÿ äàííîãî ïðåïàðàòà íå âñòðå÷àë… |
#52
|
||||
|
||||
Óâàæàåìûé Ñåðãåé,
Çà÷åì ìíå ýëåêòðîííûå àäðåñà èç Øâåéöàðèè ëþäåé, ïðîèçâîäÿùèõ ïðèáîð èëè çàíèìàþùèõñÿ åãî àïðîáàöèåé? ÿïîíñêèå êîëëåãè óæå âñå íàïèñàëè â íåäàâíåì îáçîðå - ó íèõ èäåò êëèí. èññëåäîâàíèå. Íåìåöêèå êîëëåãè ïèøóò, ÷òî íóæíû ñîîòâ. êëèí. èññëåäîâàíèÿ, àâñòðèéöû â îòâåò íà êðèò. çàìå÷àíèå Ñåðãåÿ ßðäèíà èç Ìîñêâû, ÷òî äåñêàòü íå ñëåäóåò ïîêà ïðèìåíÿòü ýêñïåðèìåíòàëüíûé ïðèáîð íà ðîññèÿíàõ, ïèøóò, ÷òî èõ îïûòû íà ÆÈÂÎÒÍÛÕ ïîêàçàëè áåçîïàñíîñòü ïðèáîðà. Âû óòâåðæäàåòå, ÷òî óäàðíûå âîëíû ñòîÿò 1000 óå â Åâðîïå, òîãäà ïîäòâåðäèòå ñâîè ñëîâà îôèöèàëüíîé ññûëêîé, ÷òî ïðèáîð ðàçðåøåí â êàêîé-òî åâðî-ñòðàíå êàê çàðåãèñò. ñðåäñòâî äëÿ ëå÷åíèÿ ÈÁÑ. Åñëè æå ýòî áûëî íà óðîâíå ÎÁÑ, òî òîãäà âîïðîñ ñíèìàåòñÿ... Ïîäîçðåâàþ, ÷òî íà îñíîâàíèè ñâîåãî ëè÷íîãî îïûòà èñïîëüçîâàíèÿ êàëèé-ãëþêîçî-ïîëÿðèçóþùåé ñìåñè èëè ïðåäóêòàëà â êàðäèîëîãèè Âû òîæå "íè êàêèå ïàòîëîãè÷åñêèå âîçäåéñòâèÿ íå âñòðå÷àëè", íî ìîæíî ëè íà ýòîì îñíîâàíèè óòâåðæäàòü, ÷òî îíè ýôôåêòèâíû â ëå÷åíèè íåñòàáèëüíîé ñòåíîêàðäèè, íàïðèìåð?
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
|
#53
|
||||
|
||||
Íà ñåãîäíÿøíèé äåíü ìåñòî ÓÂÒ âèäèòñÿ â òîì ñëó÷àå, åñëè ðåâàñêóëÿðèçàöèÿ íåâîçìîæíà, à ìàêñèìàëüíàÿ òåðàïèÿ íå ïîìîãàåò. Îò áåçûñõîäíîñòè. È òî çà ýòèõ ïàöèåíòîâ ñ íåé êîíêóðèðóåò óñèëåííàÿ íàðóæíàÿ êîíòðïóëüñàöèÿ.
|
#54
|
||||
|
||||
Tî Sergey099
Õàìñòâî â àäðåñ ìîäåðàòîðà Ôîðóìà íàêàçóåìî. Âàì ïðåäîñòàâëåíî äîñòàòî÷íî âðåìåíè äëÿ òîãî, ÷òîáû íàó÷èòüñÿ âåñòè ïðîôåññèîíàëüíûå äèñêóññèè â áîëåå ïîäîáàþùåì òîíå. P.S. Äà, íà äîñóãå ïðî÷èòàéòå âîò ýòî, áóäåò Âàì ïîëåçíî. |
#55
|
|||
|
|||
Çàíèìàåìñÿ óäàðíî-âîëíîâîé ñ èþëÿ 2008 ãîäà â Çàïîðîæüå, Óêðàèíà. Ïðîëå÷åíî 94 ïàöèåíòà. Æåëàåìûå ðåçóëüòàòû ïîëó÷åíû ó 85% ïàöèåíòîâ. Äîêëàäûâàëè â Êèåâå íà Õ Íàöèîíàëüíîì êîíãðåññå êàðäèîëîãîâ Óêðàèíû 25 ñåíòÿáðÿ 2009.  íîÿáðå áóäåò îïóáëèêîâàíà ñòàòüÿ. Âûïîëíÿåòñÿ äîêòîðñêàÿ äèññåðòàöèÿ ïî ÊÓÂÒ.
Áóäåò äîêëàä íà íàó÷íî ïðàêòè÷åñêîé êîíôåðåíöèè 2-8 íîÿáðÿ 2009 ãîäà, ã. Øàðì-Ýëü-Øåéõ, Åãèïåò. |
#56
|
|||
|
|||
Ñêîðî âûëîæó ññûëêó.
|
#57
|
||||
|
||||
Íà êàêîì îáîðóäîâàíèè ïîëó÷åíû ñòîëü óñïåøíûå ðåçóëüòàòû? Êàê ïîíèìàþ, ñòàòüÿ áóäåò â ìåñòíîé ïåðèîäèêå? Äîêëàä íå ïðîáîâàëè ïðåäñòàâèòü â êàêîé áîëåå öèâèëèçîâàííîé ñòðàíå íà êàðäèî-ñèìïîçèóìå?
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#58
|
|||
|
|||
Ìíå âîò òóò ïîäóìàëîñü, ÷òî êîãäà ÿ áûë àñïèðàíòîì, òî íèêòî è íèãäå (áëèí) ìåíÿ íå ó÷èë ìåòîäîëîãèè îðãàíèçàöèè êëèíè÷åñêèõ èññëåäîâàíèé, ïðàâèëàì íàïèñàíèÿ ñòàòåé è ïðåçåíòàöèé.  ñâÿçè ñ ÷åì ïðåäëàãàþ ïîäáîðêó äîêóìåíòîâ äëÿ òàêèõ æå êàê ÿ "ñòðàäàëüöåâ"-àñïèðàíòîâ:
1. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication 2. The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (áåç çíàíèÿ ýòîãî äîêóìåíòà îïóáëèêîâàòü ñòàòüþ â õîðîøåì æóðíàëå ïðàêòè÷åñêè íåâîçìîæíî, ïåðåâîäèì íà ðóññêèé) 3. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies 4. The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration 5. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration 6. Medical Statistic at a Glance (Î÷åíü ðåêîìåíäóþ! Óäèâèòåëüíî ïðîñòî è ïîíÿòíî íàïèñàííàÿ êíèãà î ñòàòèñòèêå) 7. Scientific Writing. Easy if you know how (BMJ group) 8. How to present at Meetings (BMJ group) P.S. Åñòü íàäåæäà, ÷òî êîãäà-íèáóäü ýòè ïðàâèëà áóäóò ñ òåì èëè èíûì óñïåõàì ïðèìåíÿòüñÿ è íà íàøèõ ïðîñòîðàõ. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#59
|
|||
|
|||
|
#60
|
||||
|
||||
Îñòàëüíûå ìîè âîïðîñû çàâèñëè â âîçäóõå...
Åñëè íå ñåêðåò, êàêîå ïèêîâîå äàâëåíèå ïðèìåíÿåòå â áàðàõ èëè ìÏà? Âàì èçâåñòíî, ÷òî ýòî îáîðóäîâàíèå, êðîìå Âàñ, íèêòî íå òåñòèðîâàë íà áåçîïàñíîñòü/ýôôåêòèâíîñòü ó ïàöèåíòîâ ñ ÈÁÑ? Ïî ññûëêå ìîæåòå ïîñìîòðåòü, ÷òî ïðèáîð ïðîõîäèò âòîðóþ ôàçó êëèí. èñïûòàíèé â Èçðàèëå (ëþáîé íîâûé ïðåïàðàò èëè ïðèáîð ìîæåò ëåãàëüíî áûòü èñïîëüçîâàí ó áîëüíûõ ïðè ïîëó÷åíèè ïîëîæèòåëüíûõ ðåçóëüòàòîâ òîëüêî â ðåçóëüòàòå òðåòüåé ôàçû êëèí. èñïûòàíèé) [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Ýòî â îáùåì îòâåòû, ïî÷åìó Âàøè ðåçóëüòàòû íå âîçìóò íè íà îäèí ïðèëè÷íûé (â ýòè÷åñêîì ïëàíå) êîíãðåññ èëè êàðäèî-æóðíàë...
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |